Ophthalmic devices for sustained delivery of active compounds

Details for Australian Patent Application No. 2006243345 (hide)

Owner Novartis AG

Inventors Lally, John Martin; Winterton, Lynn Cook

Agent Davies Collison Cave

Pub. Number AU-B-2006243345

PCT Pub. Number WO2006/117228

Priority 60/719,878 23.09.05 US; 60/677,964 05.05.05 US

Filing date 4 May 2006

Wipo publication date 9 November 2006

Acceptance publication date 18 March 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

B29D 11/00 (2006.01) Producing optical elements, e.g. lenses, prisms

G02B 1/04 (2006.01) Optical elements characterised by the material of which they are made - made of organic materials, e.g. plastics

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/117228 Priority application(s): WO2006/117228

18 March 2010 Application Accepted

  Published as AU-B-2006243345

15 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006243352-Compartmentalized resin pellets for oxygen scavenging

2006243344-Solid phase bound thymosin alpha-1 and its synthesis